The immune stimulatory unmethylated CpG motifs present in bacterial DNA (CpG DNA) induce expression of cyclooxygenase-2 (COX-2). The present study demonstrates that CpG DNA can upregulate COX-2 expression by post-transcriptional mechanisms in RAW264.7 cells. To determine the CpG DNA-mediated signaling pathway that post-transcriptionally regulates COX-2 expression, a COX-2 translational reporter (COX2-3'UTR-luciferase) was generated by inserting sequences within the 3' untranslated region (UTR) of COX-2 to the 3'end of the luciferase gene under control of the SV40 promoter. CpG DNA-induced COX2-3'UTRluciferase activity was completely inhibited by an endosomal acidification inhibitor chloroquine, a TLR9 antagonist inhibitory CpG DNA, or overexpression of a dominant negative (DN) form of 
This recruitment of MyD88 to the TIR domain of TLR9 initiates a signaling pathway that sequentially involves IL-1R-associated kinases (IRAKs) and tumor necrosis factor-α receptorassociated factor 6 (TRAF6) (3) (4) (5) (6) (7) (8) . Studies using gene-deficient mice and RAW264.7 cells transiently transfected with the dominant negative (DN) forms of these molecules indicated that were selected and maintained in complete DMEM medium plus 500 µg/ml of geneticin (G418; Calbiochem, La Jolla, CA). pOPTRAF6DN construct and pOPRSVI.mcs1 cloning vector were provided by Dr. G. Bishop at University of Iowa (Iowa City, IA) (57) . 6 cells/ml) were pretreated with DMSO or SP600125 (5 µM) for 15 min and then stimulated with medium or CpG DNA (6 µg/ml) for 45 min. In some experiments, TRAF6DN-RAW264.7 (2x10 6 cells/ml) were stimulated with medium, CpG DNA (6 µg/ml), or PMA (50 ng/ml) for 45 min. Whole cell lysates were prepared as previously described (58) . To detect the presence of a specific protein or the phosphorylation status of a specific protein, equal amounts (15 µg/lane) of whole cell lysates were subjected to electrophoresis on a 10% polyacrylamide gel containing 0.1% SDS and then western blots were performed as previously described (58) . Actin was used as a loading control. Antibodies specific for actin and the FLAG epitope tag were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA) and Eastman Kodak (New Haven, CT), respectively. Antibodies specific for the phosphorylated forms of ERK, JNK, or p38 were purchased from Cell Signaling (Beverly, MA).
Generation of DN-TRAF6 expressing RAW264.7 stable transfectants (TRAF6DN-
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Ras activation assay. Ras Activation Assay Kit was purchased from Upstate Inc.
(Charlottesville, VA) and Ras activation assay was performed according to the manufacturer's protocol. Briefly, RAW264.7 cells (1x10 7 cells) were stimulated with medium or CpG DNA (6 µg/ml) for the indicated time periods (0-30 min). Cells were harvested and lysed in Mg 2+ lysis buffer (MLB buffer). GTP bound Ras (active Ras) in cell lysates was precipitated using beadbound Raf1-RBD-GST fusion proteins that specifically bind to GTP-bound Ras. Precipitates were subjected to electrophoresis on a 14% polyacrylamide gel containing 0.1% SDS and then analyzed by western blot using an antibody specific for Ras. was added to stop transcription and then cells were further incubated for the designated time periods in the presence of medium, CpG DNA, or control non-CpG DNA. Total RNA was isolated and COX-2 mRNA levels were analyzed using Real-time PCR. As demonstrated in Figure 1B , levels of COX-2 mRNA were substantially reduced within 6 h after ActD addition in cells incubated in either medium or control non-CpG DNA. The estimated relative half-lives (t½) of COX-2 mRNA (extrapolated from Figure 1B ) were approximately 4.4 h and 5.2 h in the cells treated with medium alone and with control non-CpG DNA, respectively. In contrast, levels of COX-2 mRNA were maintained up to 6 h and then slowly declined in cells incubated in the presence of CpG DNA (t½ = 8.6 h) (Fig. 1B) . Compared to COX-2 mRNA levels in cells incubated with medium alone or control non-CpG DNA, COX-2 mRNA levels in the cells incubated with CpG DNA were substantially higher even at 9 h after ActD addition (Fig. 1B) .
These results indicate that CpG DNA may have the ability to transduce a signal that regulates COX-2 mRNA stability.
It has been reported that the 3'UTR of COX-2 contains multiple repeats of the regulatory sequence AUUUA, which is critical for post-transcriptional control of the gene, and that the first 600 nt of the COX-2 3'UTR is necessary and sufficient for the regulation of mRNA stability and translational efficiency (45, 46, 48) . To further investigate how CpG DNA post-transcriptionally regulates COX-2 expression, a COX-2 translational reporter gene construct (COX2-3'UTR-luc) was generated by inserting the 3'-UTR (nucleotides 1-792) of the COX-2 sequence to the 3' end of the luciferase gene under control of the SV40 promoter and enhancer elements ( Fig. 2A) .
Since both the pGL3-luciferase reporter construct and the COX2-3'UTR-luciferase reporter construct have identical promoter elements, differences in luciferase activity reflect differences in regulation as a result of post-transcriptional events. The negative regulatory function of the COX-2 3'UTR was analyzed. As shown in Figure 2B , insertion of the COX-2 3'UTR to the 3'
end of the luciferase gene in the pGL3-control vector resulted in an approximately 95 % reduction in the luciferase activity, indicating the presence of a functional negative regulatory element within the 3'UTR of the COX-2.
To investigate the ability of CpG DNA to transduce signals post-transcriptionally regulating COX-2 expression, RAW264.7 cells were transfected with a COX-2 translational reporter (COX2-3'UTR-luc) and then stimulated with medium, CpG DNA, control non-CpG DNA, or LPS. As shown in Figure 2C , both CpG DNA and LPS, but not control non-CpG DNA, induced increases of COX2-3'UTR-luciferase activity. This indicates that, like LPS, CpG DNA also has ability to induce COX-2 expression by post-transcriptional regulation mechanisms. To further confirm that COX2-3'UTR-luciferase activity induced by CpG DNA was mediated through a TLR9-dependent pathway, and not due to LPS contamination, RAW264.7 cells were transfected with COX2-3'UTR-luc reporter and then stimulated with medium, CpG DNA, or LPS in the presence or absence of a TLR9 antagonist inhibitory CpG DNA (iCpG DNA). Of note, the recently identified iCpG DNA specifically blocks the effects of results showed that overexpression of DN-TRAF6 only partially inhibits CpG DNA-induced COX2-3'UTR luciferase activity (Fig. 4C) . Therefore, we hypothesized that this partial contains a 603-nt 3'UTR (64, 65) . Previous studies have demonstrated that insertion of the 3'UTR of COX-2 to the 3' end of a reporter gene alters its expression, and the ARE sequences are crucial for this response (45, 46, 48) . These studies demonstrated that a region 123 nt immediately 3' to the translation termination codon contains a highly conserved ARE (CR1), composed of 6 AUUUA elements, and that CR1 is necessary and sufficient to regulate both COX-2 message stability and translational efficiency (45, 46, 48) . the presence of the transcriptional inhibitor ActD (Fig. 1B) and reversed the inhibition of luciferase activity caused by insertion of COX-2 3'UTR (Fig. 2C) . These results suggests that CpG DNA stabilizes COX-2 mRNA and that increases in COX2-3'UTR-luciferase activity induced after CpG DNA stimulation may be due, at least in part, to increased mRNA stability.
The involvement of TLR9 in transducing the CpG DNA signal to post-transcriptionally regulate COX-2 expression was indirectly shown by using a TLR9 antagonist iCpG DNA (Fig.   2D ). Although there has been no formal demonstration showing that either CpG DNA or iCpG DNA directly binds to TLR9, and the precise molecular mechanism by which iCpG DNA specifically blocks the activity of CpG DNA has not been revealed, previous studies suggest that iCpG DNA may compete with CpG DNA for binding to TLR9 (59) (60) (61) . Utilization of TLR9 for
CpG DNA-mediated post-transcriptional regulation of COX-2 expression was also supported by demonstrating that chloroquine, an endosomal acidification inhibitor, completely blocked CpG DNA-induced COX2-3'UTR-luciferase activity (Fig. 3) . It has previously been demonstrated that an endosomal acidification inhibitor such as chloroquine abolishes the biologic effects of CpG DNA by inhibiting binding of CpG DNA to TLR9 and the subsequent recruitment of MyD88 to TLR9 (2, 4, 62, 63) . Recent studies have demonstrated the absolute requirement of MyD88 for the CpG DNA-mediated activation of NF-κB, JNK, and p38, and their subsequent biologic effects including proinflammatory cytokine production and B cell proliferation (3) (4) (5) . In addition, we have recently demonstrated that MyD88 is indispensable for CpG DNA-mediated COX-2 transcriptional regulation (28) . In agreement with these previous observations, our results also showed that transient overexpression of DN-MyD88 completely inhibits the ability of CpG DNA to induce COX2-3'UTR-luciferase activity and AP-1 transcriptional activity ( Fig.   4A ) (28) . (Fig. 6C) , indicating that CpG DNA induces activation of ERK through a signaling pathway that is independent of TRAF6, and that TRAF6 may be a diverging point for the activation of MAPKs in the TLR9/MyD88-signaling pathway. While p38 is the only MAPK required for the transcriptional regulation of COX-2 expression by CpG DNA (28) , the optimal induction of COX2-3'UTR-luciferase activity by CpG DNA requires all three active MAPKs, ERK, JNK, and p38 (Fig. 5) . Therefore, this TRAF6-independent activation of ERK by CpG DNA may explain the reason that DN-TRAF6 only partially blocks the CpG DNAmediated post-transcriptional regulation of COX-2 expression (Figs. 4C and 6D ).
In the classical ERK activation pathway, the small GTP-binding protein Ras is the upstream activator of Raf1. Previous studies have demonstrated that CpG DNA induces activation of Raf1 and MEK1/2, and that active Raf1 and MEK1/2 are required for CpG DNAmediated ERK activation (58, 63) . In the present study, we have found that CpG DNA rapidly induces activation of Ras in RAW264.7 cells (Fig. 7A) and that Ras plays a functional regulatory role in the CpG DNA-mediated post-transcriptional regulation of COX-2 expression (Fig. 7B) .
Moreover, co-expression of both DN-TRAF6 and N17Ras results in complete inhibition of COX-2-3'UTR-luciferase activity in response to CpG DNA ( has been shown to be critical for COX-2 mRNA stabilization by cytokines, serum withdrawal, or LPS (48, 50, 51, 72) . The ERK1/2 pathway has been shown to be essential for stabilizing COX-2 mRNA in response to IL-1β in human endometrial stromal cells (73) . Ceramide-induced COX-2 mRNA stabilization in rat intestinal epithelial cells requires both p38 and ERK but not JNK (74) . Our results demonstrated that in addition to ERK1/2 and p38, JNK also contributes to the CpG DNA-mediated post-transcriptional regulation of COX-2 expression in RAW264.7 cells (Fig. 5) . Post-transcriptional regulation is not limited to changes in message stability, and sequences within the 3'UTR of mRNAs have also been shown to be important for enhancing message translation as well as for translational silencing (45, 75, 76) . Since the 3'UTR of murine COX-2 also contains multiple regulatory elements that alter message stability and translational efficiency (45), results from the assay system we employed for the present study collectively reflect post-transcriptional regulatory mechanisms but do not differentiate translational efficiency or translational silencing from message stabilization. Therefore, it is yet to be determined whether each MAPK plays a different regulatory role in CpG DNA-regulated COX-2 message stability, translational efficiency and translational silencing.
In summary, the present study demonstrates for the first time that CpG DNA has ability to post-transcriptionally regulate gene expression through a TLR9/MyD88-dependent signaling pathway and that CpG DNA induces ERK activation through a TRAF6-independent manner.
Our results indicate that TRAF6 may be a diverging point for the activation of MAPKs in the TLR9/MyD88-signaling pathway. were stimulated with medium, CpG DNA (3µg/ml), or non-CpG DNA (3µg/ml) for the designated time periods. Total RNA was isolated and the presence of mRNA for COX-2 and GAPDH in each sample was detected by real-time PCR using SYBR green. GAPDH was used as an endogenous control. Data present the mean (fold induction from unstimulated control) ± SD of triplicates. The experiment was done three times with similar results. Panel B.
RAW264.7 cells pretreated with CpG DNA (3µg/ml) for 12h were stimulated with medium, CpG DNA (3µg/ml), or non-CpG DNA (3µg/ml) for the designated time periods in the presence of Actinomycin D (10 µg/ml). Total RNA was isolated and the presence of mRNA for COX-2
and GAPDH in each sample was detected by real-time PCR using SYBR green. GAPDH was used as an endogenous control. Data present the mean (% of unstimulated control) ± SD of triplicates. The experiment was done three times with similar results. A.
